Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hematologic Neoplasms 2Prostatic Neoplasms, Castration-Resistant 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mastocytosis, Systemic 1Lymphoma 1Leukemia, Mast-Cell 1Leukemia, Biphenotypic, Acute 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 20fludarabine phosphate 17Whole-Body Irradiation 15fludarabine 14Melphalan 14Tacrolimus 13Busulfan 12Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Cyclosporine 6Antilymphocyte Serum 6Alemtuzumab 6Methotrexate 5Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3sargramostim 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2visilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × ibrutinib × Myeloid × Clear all
NCT04439006 2023-12-26

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
10 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡